Lenacapavir, sold under the brand names Sunlenca among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is taken by mouth or by subcutaneous injection. Lenacapavir is a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor.
via Wikipedia infobox
{{Infobox drug | image = Lenacapavir.svg | image_class = skin-invert-image | alt = | caption = Molecular structure of lenacapavir | image2 = Lenacapavir 3D.png | image_class2 = bg-transparent | pronounce = | tradename = Sunlenca, Yeztugo, others | Drugs.com = | MedlinePlus = a623005 | DailyMedID = Lenacapavir | pregnancy_AU = B1 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth, subcutaneous | caption2 = 3D representation of a lenacapavir molecule | class = Capsid inhibitors | ATC_prefix = J05 | ATC_suffix = AX31
| legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = Rx-only | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = | duration_of_action = | excretion = | CAS_number = 2189684-44-2 | CAS_supplemental = | PubChem = | IUPHAR_ligand = | DrugBank = DB15673 | ChemSpiderID = 81367881 | UNII = A9A0O6FB4H | KEGG = D12161 | KEGG2 = D12162 | ChEBI = | ChEMBL = 4594438 | NIAID_ChemDB = | PDB_ligand = QNG | synonyms = GS-CA2, GS-6207
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).